Changying Jiang

555 total citations
15 papers, 393 citations indexed

About

Changying Jiang is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Changying Jiang has authored 15 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Changying Jiang's work include Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Biochemical and Molecular Research (3 papers). Changying Jiang is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Biochemical and Molecular Research (3 papers). Changying Jiang collaborates with scholars based in United States, China and Russia. Changying Jiang's co-authors include Yun You, Xin Lin, Lele Zhu, Xin‐Ming Jia, Xue Qiang Zhao, Xiao‐Ping Chen, Mien‐Chie Hung, Jing‐Yu Lang, Brian C. Grabiner and Yifan Zhu and has published in prestigious journals such as Blood, Immunity and Cancer Research.

In The Last Decade

Changying Jiang

13 papers receiving 392 citations

Peers

Countries citing papers authored by Changying Jiang

Since Specialization

Citations

This map shows the geographic impact of Changying Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changying Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changying Jiang more than expected).

Fields of papers citing papers by Changying Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changying Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changying Jiang. The network helps show where Changying Jiang may publish in the future.

Co-authorship network of co-authors of Changying Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Changying Jiang. A scholar is included among the top collaborators of Changying Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changying Jiang. Changying Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Improved medical protective clothing comfort for medical staff facing high-intensity infectious diseases 2025 ·Frontiers in Public Health ·Changying Jiang, (unknown), Rong Zhang, (unknown), Huyong Zheng, (unknown), (unknown), Chuang Nie, Jianwen Gu	0
2	HSP27 Promotes Mantle Cell Lymphoma Growth and Mediates Resistance to Venetoclax 2022 ·Blood ·Yuxuan Che, (unknown), Yang Liu, Heng‐Huan Lee, Yijing Li, Zhihong Chen, (unknown), Changying Jiang, Yixin Yao, Michael Wang	1
3	Establishment of a Patient-Derived Organoid Culture Platform for Mantle Cell Lymphoma Drug Sensitivity and CAR T Cell Anti-Tumor Activity Assay 2022 ·Blood ·(unknown), Yang Liu, Changying Jiang, Yuxuan Che, Jingling Jin, Qingsong Cai, Wei Wang, Yijing Li, (unknown), (unknown), (unknown), Yixin Yao, Heng‐Huan Lee, Michael Wang	0
4	Abstract 1112: Exploiting oncogene-conferred glutamine addiction as a therapeutic vulnerability in resistant mantle cell lymphoma 2021 ·Cancer Research ·Lingzhi Li, Changying Jiang, Lucy Navsaria, Yang Liu, (unknown), Michael Wang, (unknown)	1
5	Pirtobrutinib Overcomes Ibrutinib and Venetoclax Resistance in Mantle Cell Lymphoma 2021 ·Blood ·Yang Liu, Changying Jiang, Fangfang Yan, (unknown), (unknown), Yijing Li, Yuxuan Che, Qingsong Cai, Wei Wang, Lei Nie, Michael Wang	4
6	Abemaciclib in Combination with Copanlisib to Overcome Therapeutic Resistance in Mantle Cell Lymphoma 2021 ·Blood ·Yuxuan Che, Yang Liu, Yijing Li, (unknown), (unknown), Zhihong Chen, Fangfang Yan, Wei Wang, Jingling Jin, Changying Jiang, Yixin Yao, Michael Wang	1
7	Targeting Glutamine Metabolism Overcomes Resistance to Targeted Therapies in Refractory Mantle Cell Lymphoma 2020 ·Blood ·Lingzhi Li, Changying Jiang, Lucy Navsaria, Yang Liu, (unknown), Michael Wang, Yixin Yao	3
8	Genome-Wide Identification and Expression Analysis of Polygalacturonase Gene Family in Kiwifruit (Actinidia chinensis) during Fruit Softening 2020 ·Plants ·Wenjun Huang, (unknown), Tingting Zhao, (unknown), Qi Zhang, Xiaoli Liu, Changying Jiang, Caihong Zhong	31
9	COPANLISIB AND VOLASERTIB OVERCOME IBRUTINIB‐VENETOCLAX RESISTANCE VIA TARGETING PI3K‐AKT SIGNALING AND G2/M CELL CYCLE TRANSITION IN MANTLE CELL LYMPHOMA 2019 ·Hematological Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Krystle Nomie, Changying Jiang, M. Wang	1
10	Targeting PI3K and PLK1 to Overcome Ibrutinib-Venetoclax Resistance in Mantle Cell Lymphoma 2019 ·Blood ·Changying Jiang, Rongjia Zhang, Shaojun Zhang, William Lee, Shengjian Huang, Yang Liu, (unknown), (unknown), Preetesh Jain, Krystle Nomie, Linghua Wang, Michael Wang	7
11	Abstract 3459: Dual targeting of BTK and PLK1 causes lethal synergistic effects in mantle cell lymphoma 2018 ·Cancer Research ·Changying Jiang, Shengjian Huang, Yang Liu, Krystle Nomie, Leo Yu Zhang, Michael Wang	1
12	Resistance Mechanisms Underlying Venetoclax Resistance in Mantle Cell Lymphoma 2017 ·Blood ·Shengjian Huang, Changying Jiang, Hui Guo, Jeffrey Wang, Yang Liu, (unknown), (unknown), Hui Zhang, (unknown), (unknown), Swathi Balaji, Makhdum Ahmed, Krystle Nomie, Liang Zhang, Michael Wang	8
13	A cross-sectional study to investigate the correlation between depression comorbid with anxiety and serum lipid levels 2016 ·Comprehensive Psychiatry ·Jinmin Wang, Changying Jiang, Liling Chen, (unknown), (unknown), Lili Gao, (unknown), (unknown), (unknown), Shiju Li, Xiaoming Pan, (unknown)	19
14	C-Type Lectin Receptors Dectin-3 and Dectin-2 Form a Heterodimeric Pattern-Recognition Receptor for Host Defense against Fungal Infection 2013 ·Immunity ·Lele Zhu, Xue Qiang Zhao, Changying Jiang, Yun You, Xiao‐Ping Chen, (unknown), Xin‐Ming Jia, Xin Lin	245
15	CARMA3 is Crucial for EGFR-Induced Activation of NF-κB and Tumor Progression 2011 ·Cancer Research ·(unknown), Brian C. Grabiner, Yifan Zhu, Changying Jiang, Hongxiu Li, Yun You, Jing‐Yu Lang, Mien‐Chie Hung, Xin Lin	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact